BSE Live
Nov 14, 16:01Prev. Close
266.95
Open Price
267.20
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Nov 14, 15:48Prev. Close
267.25
Open Price
267.25
Bid Price (Qty.)
262.90 (40)
Offer Price (Qty.)
0.00 (0)
| Key Financial Ratios of Indoco Remedies (in Rs. Cr.) | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | |
| Per Share Ratios | ||||||
| Basic EPS (Rs.) | 2.63 | -0.31 | 4.47 | 8.40 | 9.04 | |
| Diluted EPS (Rs.) | 2.63 | -0.31 | 4.47 | 8.40 | 9.04 | |
| Cash EPS (Rs.) | 10.32 | 7.46 | 11.82 | 15.27 | 15.59 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 73.81 | 71.74 | 73.31 | 70.74 | 63.40 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 73.81 | 71.74 | 73.31 | 70.74 | 63.40 | |
| Dividend / Share(Rs.) | 0.30 | 0.30 | 1.00 | 1.60 | 1.60 | |
| Revenue from Operations/Share (Rs.) | 120.02 | 105.02 | 112.66 | 116.34 | 108.56 | |
| PBDIT/Share (Rs.) | 13.65 | 8.99 | 15.15 | 17.45 | 18.83 | |
| PBIT/Share (Rs.) | 5.96 | 1.23 | 7.81 | 10.58 | 12.28 | |
| PBT/Share (Rs.) | 3.12 | -1.00 | 5.26 | 9.91 | 10.95 | |
| Net Profit/Share (Rs.) | 2.63 | -0.31 | 4.47 | 8.41 | 9.04 | |
| Profitability Ratios | ||||||
| PBDIT Margin (%) | 11.37 | 8.56 | 13.44 | 14.99 | 17.34 | |
| PBIT Margin (%) | 4.96 | 1.16 | 6.92 | 9.09 | 11.31 | |
| PBT Margin (%) | 2.59 | -0.95 | 4.66 | 8.51 | 10.08 | |
| Net Profit Margin (%) | 2.19 | -0.29 | 3.96 | 7.22 | 8.32 | |
| Return on Networth / Equity (%) | 3.56 | -0.42 | 6.09 | 11.88 | 14.26 | |
| Return on Capital Employed (%) | 6.75 | 1.38 | 8.76 | 12.08 | 12.34 | |
| Return on Assets (%) | 1.90 | -0.22 | 3.32 | 6.46 | 8.65 | |
| Total Debt/Equity (X) | 0.30 | 0.37 | 0.35 | 0.38 | 0.22 | |
| Asset Turnover Ratio (%) | 86.92 | 76.90 | 83.86 | 89.54 | 103.92 | |
| Liquidity Ratios | ||||||
| Current Ratio (X) | 1.22 | 1.20 | 1.29 | 1.46 | 1.60 | |
| Quick Ratio (X) | 0.77 | 0.79 | 0.82 | 0.99 | 1.03 | |
| Inventory Turnover Ratio (X) | 5.31 | 5.28 | 5.37 | 5.79 | 6.14 | |
| Dividend Payout Ratio (NP) (%) | 11.40 | -324.34 | 35.79 | 2.37 | 17.69 | |
| Dividend Payout Ratio (CP) (%) | 2.90 | 13.40 | 13.53 | 1.30 | 10.26 | |
| Earnings Retention Ratio (%) | 88.60 | 424.34 | 64.21 | 97.63 | 82.31 | |
| Cash Earnings Retention Ratio (%) | 97.10 | 86.60 | 86.47 | 98.70 | 89.74 | |
| Valuation Ratios | ||||||
| Enterprise Value (Cr.) | 2,094.43 | 2,073.76 | 2,163.47 | 2,491.57 | 2,765.54 | |
| EV/Net Operating Revenue (X) | 1.89 | 2.14 | 2.08 | 2.32 | 2.76 | |
| EV/EBITDA (X) | 16.65 | 25.03 | 15.49 | 15.50 | 15.94 | |
| MarketCap/Net Operating Revenue (X) | 1.74 | 1.93 | 1.87 | 2.15 | 2.65 | |
| Retention Ratios (%) | 88.59 | 424.34 | 64.20 | 97.62 | 82.30 | |
| Price/BV (X) | 2.84 | 2.83 | 2.87 | 3.53 | 4.54 | |
| Price/Net Operating Revenue | 1.74 | 1.93 | 1.87 | 2.15 | 2.65 | |
| Earnings Yield | 0.01 | 0.00 | 0.02 | 0.03 | 0.03 |
12.11.2025
Indoco Remedies Standalone September 2025 Net Sales at Rs 442.12 crore, up 11.5% Y-o-Y
07.11.2025
Indoco Remedies Consolidated September 2025 Net Sales at Rs 484.67 crore, up 12.02% Y-o-Y
25.07.2025
24.07.2025
Indoco Remedies Consolidated June 2025 Net Sales at Rs 437.89 crore, up 1.48% Y-o-Y
12.11.2025
Indoco Remedies Standalone September 2025 Net Sales at Rs 442.12 crore, up 11.5% Y-o-Y
07.11.2025
Indoco Remedies Consolidated September 2025 Net Sales at Rs 484.67 crore, up 12.02% Y-o-Y
24.07.2025
Indoco Remedies Consolidated June 2025 Net Sales at Rs 437.89 crore, up 1.48% Y-o-Y
24.07.2025
Indoco Remedies Standalone June 2025 Net Sales at Rs 392.53 crore, down 2.22% Y-o-Y
12.07.2023
Indoco Remedies Q1 PAT may dip 0.1% YoY to Rs 38.5 cr: Nirmal Bang
17.01.2023
Indoco Remedies Q3 PAT seen up 46.1% YoY to Rs 482 cr: Nirmal Bang
08.07.2022
Indoco Remedies Q1 PAT seen up 4.4% YoY to Rs 41.4 cr: Prabhudas Lilladher
14.04.2022
Indoco Remedies Q4 PAT seen up 52.9% YoY to Rs 38.2 cr: Prabhudas Lilladher